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Abstract
Stringently controlled conditional expressing systems are crucial for the functional characterization of genes. Currently,
screening of multiple clones to identify the tightly controlled ones is necessary but time-consuming. Here, we describe a
system fusing Tet (tetracycline)-inducible elements, BAC (bacterial artificial chromosome) and Gateway technology together
to allow tight control of gene expression in BAC-transfected eukaryotic bulk cell cultures. Recombinase cloning into the
shuttle vector and the BAC facilitates vector construction. An EGFP (enhanced green fluorescent protein) allows FACS
(fluorescence activated cell sorting) and the BAC technology ensures tight control of gene expression that is independent of
the integrating site. In the current first application, our gene of interest encodes a b-catenin-ERa fusion protein. Tested by
luciferase assay and western blotting, in HTB56 lung cancer cells the final BAC E11-IGR-b-catenin-ERa vector demonstrated
sensitive inducibility by Tet or Dox (doxycycline) in a dose-dependent manner with low background, and the EGFP was an
effective selection marker by FACS in bulk culture HTB56 and myeloblastic 32D cells. This is a highly efficient tool for the
rapid generation of stringently controlled Tet-inducible systems in cell lines.
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Introduction
The rapid development of genomic functional research requires
stringently controlled expression systems. Tet (tetracycline)-regulat-
ed expression systems are widely used. Tet-inducible systems are
divided into two classes: one is TetOff, which is constitutively active
in the absence of Tet or Dox (doxycycline), whereas off in the
presence of Tet or Dox [1,2]; the other one is TetOn, which
becomes active only in the presence of Tet or Dox [3]. One of the
advantages of the TetOn system is that, after addition of the
inducer, the induction is more rapidly than with the TetOff system
following depletion of Tet or Dox. Additionally, gene expression
levels can be controlled by adding different doses of inducers [4].
So far, several kinds of vectors have been used to construct Tet or
Dox-inducible expression systems such as lentiviral [5,6], retroviral
[7], adeno-associated viral [1,2,8–11], first-generation adenoviral
[2,9,10], herpesviral [12], high-capacity adenoviral [13–18] and the
bacterial artificialchromosome(BAC) vectors[19].BACvectors are
optimal for harboring relatively long fragments of genomic DNA
or large cDNA in excess of 100 kb. They have the considerable
advantages of stable propagation and ease of purification.
Importantly, as a genomic DNA fragment with effective insulator
characteristics, BAC vectors enable the generation of transgenic
mammalian cells with predictable expression characteristics inde-
pendent of the integration site, so they are currently often used in
genetic research, such as library construction, transgenic mice
production, and gene targeting constructs [20,21].
However, it is often cumbersome to clone genes into BAC
including two steps: first, clone a gene of interest into an
intermediate shuttle vector by traditional restriction digestion
and ligation; second, the gene of interest is recombined into BAC
from the shuttle vector. In the case of multiple expression and
functional analysis, proper restriction sites have to be selected
according to the different sequences of genes in above-mentioned
step I, and then step II is repeated. It is a time- and money-
consuming process. However, this work could be simplified by
Gateway Technology using lambda phage-based site-specific
recombination instead of restriction endonuclease and ligase to
insert a gene of interest into the shuttle vector. The DNA
recombination sequences (attL, attR, attB, and attP) and the LR or
BP Clonase enzyme mixtures that mediate the lambda recombi-
nation reactions are the foundation of Gateway Technology. In
our current study, we cloned a versatile shuttle vector pIGR-RFC.
To use this system, the gene of interest is cloned into an entry
vector (pENTR), which is then mixed in vitro with pIGR-RFC and
the Gateway Clonase enzyme mixtures. Site-specific recombina-
tion between the att sites (attRxattL) generates an expression clone
and a by-product. Thus, the reading frame C (RFC) in the shuttle
vector is replaced by the gene of interest [22]. In this way, different
genes of interest can now easily be cloned into a universal shuttle
vector and then into a BAC.
In our former utilization of Tet-controlled BAC in generating
transgenic mice, it appeared that some strains have strong Tet-
inducible expression of gene, while others do not, indicating clonal
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money-consuming selection of dozens of clones, the enhanced
green fluorescent protein (EGFP) may be used as a selection
marker because of its convenience for fluorescence activated cell
sorting (FACS). By the means of flow cytometry, positive-
transfected cells can be easily purified. Thus, in cellular and
animal experiments EGFP could act as a useful visible marker by
the fluorescence in positive clones.
To the best of our knowledge, our current Tet-controlled
expression system is the first combination of Tet-inducible
elements, BAC and Gateway technology. It boasts the tight and
quantitative expression inducibility by Tet or Dox, the gene
cloning convenience by Gateway technology, stable expression in
BAC vector and efficient selection for EGFP contributing to a
universal technical tool for the analysis of gene expression and its
function.
Methods
Contruction of pIGR-RFC
RFC (Invitrogen, Calsbad, CA, USA), EGFP, IRES and all the
elements of Tet-inducible expression system were cloned into
pE11.F3.M.F. (established by Dr. K. Scho ¨nig, and kindly provided
by Dr. H. Bujard), and pIGR-RFC was generated. The map of
pIGR-RFC is shown in Figure 1A and C. Its DNA sequence is
provided as supplementary material (Supporting Information S1).
Cell Culture
HTB56 cell line from American Type Culture Collection
(ATCC) was cultured in Modified Eagle’s medium (Invitrogen,
Calsbad, CA, USA) supplemented with 10% Tet-free fetal calf
serum (FCS), 1% non-essential amino acids, 1 mM sodium
pyruvate, 2 mM L-glutamine, 100 units/ml penicillin and
100 mg/ml streptomycin at 37uCi n5 %C O 2. The 32D cells
were cultured and maintained as described earlier [23].
BAC Transfection
HTB56 cells were seeded 8 hours before transfection into 6-well
plates with a density of 300,000 cells per well. Transfection was
performed with Lipofectamine transfection reagent (Invitrogen,
Carlsbad, CA, USA) by using 1 mg of super-coiled BAC DNA per
well. For luciferase assay, 0.1 mg of pRLSV40 encoding renilla
luciferase was cotransfected with BAC as internal control to
normalize the transfection efficiency. Tet or Dox (Sigma, St.
Louis, MO, USA) was added into the culture medium 24 hours
after transfection.
Before transfection into 32D cells, the supercoiled BAC DNA
was linearized by digestion with I-SceI restriction enzyme (New
England Biolabs, Ipswich, MA, USA). For electroporation, 3610
6
32D cells suspended in 300 ml culture medium were transferred
into an electrocuvette with a diameter of 4 mm containing 32 mg
linearized BAC DNA. The electrical conditions were at 300 V,
6 ms using Pulse Generator EPI 2500 (Fischer, Heidelberg,
Germany).
Dual-Luciferase Activity Assay
Activities of the firefly luciferase and Renilla luciferase in a
single sample were measured sequentially using the Dual-
Luciferase Report Assay System (Promega, Madison, Wisconsin,
USA). Briefly, after 24 hours of Tet or Dox treatment, cells were
rinsed twice with phosphate-buffered saline (PBS) and then lysed
in 120 ml of passive lysis buffer at room temperature for 15 min.
10 ml of the cell lysate were quickly mixed with 100 mlo f
Luciferase assay reagent in a luminometer tube. The light emission
for the firefly luciferase was recorded for 10 s after a 5 s
premeasurement delay using a TD-20/20 luminometer (Turner
Designs Instrument, CA, USA). Subsequently, 100 ml of Stop&Glo
reagent was added to the same tube to inactivate the firefly
luciferase while activating the Renilla luciferase. Variation in
transfection efficiency was normalized by dividing the value of the
firefly luciferase activity with that of the Renilla luciferase activity.
Western Blot Analyses
For preparation of whole-cell lysates cells were washed with ice-
cold PBS and lysed for 30 minutes on ice in RIPA buffer with
150 mM NaCl as described [24]. Cell lysates were cleared at 20
000 g for 10 minutes. After adjustment of protein concentrations,
the lysates were boiled in SDS sample loading buffer for 5 minutes
and separated by SDS-polyacrylamide gel electrophoresis (PAGE,
4–12%, Invitrogen). Gels were blotted on a polyvinylidene
difluoride (PVDF) membrane (Millipore, Bedford, MA, USA)
and stained with the anti-human b-catenin first antibody
(0.38 mg/ml, BD Biosciences, NJ, USA). Antibody binding was
detected with a horseradish peroxidase (HRP)-coupled secondary
antibody followed by chemoluminescence detection (ECL Plus,
Amersham Pharmacia, Uppsala, Sweden).
Statistics
Quantitative data are presented as means plus standard
deviation (SD). Statistical analyses were performed with SPSS,
version 10.0 (SPSS Science, Chicago, IL, USA). Statistical
significances of overall differences between multiple groups were
analyzed by one-way ANOVA analysis. P values of 0.05 or less
were considered significant.
Results and Discussion
To clarify the functional roles of various candidate genes
screened by microarray, we established a Tet-inducible expressing
system. As shown in Figure 1, the system we are describing here
consists of a pENTR vector, an intermediate vector pE11-IGR-
RFC and BAC E11. The pE11-IGR-RFC vector accommodates
all the elements required for Tet-regulated gene expression
including two expression cassettes, one of which encodes the
elements responsive to Tet or Dox, and the other one of which
encodes the rtTA2
S-M2, an optimized rtTA construct exhibiting
significantly increased sensitivity to Dox [25]. An internal
ribosome entry site (IRES) is added between the rtTA2
SM2 and
EGFP to allow expression of these two genes driven by a single
hCMV promoter. The EGFP acts as a sorting marker by flow
cytometry in eukaryotic cells. The Tet-responsive expression
cassette contains a bidirectional promoter Ptetbi, driving expression
of two genes simultaneously. The firefly luciferase is a surrogate
marker for the expression of the gene of interest, which can be
conveniently recombined into Gateway RFC from a pENTR
vector. In the current study, the gene of interest is the b-catenin-
ERa fusion gene (Fig. 1B). The backbone of pE11-IGR-gene of
interest also comprises two homologous arms HA-A and HA-B
sites for recombination with BAC in special bacteria resulting in a
destination BAC E11-IGR-gene of interest (Fig. 1D).
Then, tetracycline inducibility of BAC E11-IGR-gene of
interest was evaluated. HTEB56 cells transiently transfected by
E11-IGR-b-catenin-ERa were exposed to different doses of Tet,
Dox or not. We assayed the activity of luciferase, a sensitive
surrogate marker reflecting the expression of the gene of interest in
the other direction of Ptetbi. As shown in Figure 2A, there is a dose
dependent induction of luciferase activity to 0.05,5 mg/ml Tet or
0.01,1 mg/ml Dox. The BAC vector is more sensitive to Dox
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PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6445Figure 1. Schematic engineering of the tetracycline-controlled BAC system. (A) Linear depiction of pE11-IGR-RFC vector, which is an
intermediate vector including all elements for conditional expression regulated by tetracycline. The promoter Ptetbi allows simultaneous bidirectional
expression: in one direction is the reading frame C (FRC) of Gateway system, into which the gene of interest can be recombined from pENTR plasmid
conveniently, and in the other direction is luciferase as a surrogate marker for the expression of the inserted gene of interest. The sequence of rtTA2
S-
M2, a reverse transactivator of Ptetbi driven by hCMV was also cloned into this shuttle vector. To avoid inserting a third expression cassette, an
internal ribosome entry site (IRES) was added between the rtTA2
SM2 and the EGFP to allow translation and expression of these two proteins from a
single promoter hCMV. The homologous arms HA-A and HA-B serve as recombination sites between pE11 and the BAC. (B) A gene of interest is
cloned into pENTR vector using proper restriction enzyme sites and the gene of bacteria-toxic protein ccdB is replaced. (C) The sites of attL1 and attL2
in pENTR are recombined with corresponding sites attR1 and attR2 in RFC respectively. As a result, the gene of interest is engineered into pE11-IGR-
RFC and the product is pE11-IGR-gene of interest. (D) The vector pE11-IGR-gene of interest is first linearized by Pme I restriction enzyme and then
transduced into BAC E119s host bacteria, within which recombinase is activated by heating (15 min at 42uC). Finally, the gene of interest and all the
elements of tetracycline regulation are cloned into BAC.
doi:10.1371/journal.pone.0006445.g001
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ml, the luciferase activity is over 80 times higher than that in the
absence of Tet and Dox (P,0.001). The dose-dependent
inducibility indicated that the expression level of the gene of
interest can be regulated deliberately by adding different doses of
Dox. In this way, the expression of the gene of interest is controlled
not only qualitatively but also quantitatively in transiently
transfected bulk cultures.
Furthermore, the inducible expression of b-catenin-ERa was
evaluated. In our current study, we used pENTR-b-catenin-ERa
as a donor for in vitro recombination with Gateway RFC (Fig. 1B).
The fusion gene b-catenin-ERa encodes a chimaeric protein
comprising wild type b-catenin fused with hormone binding
domain of estrogen receptor a. As a result, the DNA fragment of
b-catenin-ERa is recombined into BAC. Western blotting was
performed after treatment with the indicated concentrations of
Dox or Tet for 24 hours. The molecular weight of b-catenin-ERa
fusion protein and wild type b-catenin is 136 and 92 kD
respectively. Our antibody to b-catenin recognized both b-
catenin-ERa fusion protein and the endogenous wild type b-
catenin which acted as loading control. In line with the results of
the luciferase assay, the expression of b-catenin-ERa was induced
by Dox in a dose-dependent manner. Also, Tet (5 mg/ml) induced
significant expression of b-catenin-ERa with very low background
in non-Tet exposed cells. Importantly, the very low background
suggests very little leakiness of inducibility in our current system,
which makes it possible to control the expression of the gene of
interest in a very stringent mode.
As a selection marker, EGFP positive cells can be sorted by
FACS after transfection. In the final vector BAC E11-IGR-b-
catenin-ERa, the expression of EGFP is constitutive and
independent of the Tet-regulated cassette. As shown in Figure 3,
there are less than 10% green cells 48 hours after transfection,
however, around 70% after sorting by flow cytometry. This result
indicated that the EGFP is an effective marker for FACS selection.
The relatively low transfection efficiency is likely due to the large
size (over 100 kb) of the BAC vector. There have been reports of
successful transfection of supercoiled BAC DNA into Hela cells
with Effectene reagent (Qiagen, Valencia, CA) [26]. In HTB56
cells, we used lipofectamine reagent (Invitrogen). Although the
transient transfection efficiency is not high, the low background
and high inducibility guarantee usefulness of this BAC system for
transient transfection studies. Also, we succeeded in electropora-
tion of linearized (see materials and methods section) BAC E11-
IGR-b-catenin-ERa into 32D cells. It is suggested that it is
necessary to optimize the transfection conditions in view of cell line
specificity. Another cause of the low percentage of green cells is
that the final vector BAC E11-b-catenin-ERa is not able to
replicate episomally. One of the reasons why the expression of
some episomal replicating vectors are not stable over time is that
the selection can not distinguish episomal and genomic integrated
ones, and the episomal expression is not as stable as that of the
integrated [25]. Considering expression stability, we did not design
a eukaryotic Ori in the final vector BAC E11-gene of interest. The
advantage is that in the stable cell lines we will get, our gene of
interest has integrated into the genome compared to the analysis of
multiple clones.
In summary, our current Tet-controlled BAC system has tight
and dose-dependent inducibility especially to Dox. It is a potential
tool to study the functional role of unknown genes in bulk, for
example, genes that have been identified in a high-throughput and
comprehensive manner.
Figure2.TetracyclineinducibilityofBACE11-IGR-b-catenin-ERa.
As a gene of interest, the coding sequence of b-catenin-ERa fusion
protein is engineered into BAC. (A) The activity of firefly luciferase, a
surrogate marker is assayed to reflect the activity of Ptetbi. HTB56 cells
cultured in 6-well plates (300,000 per well) were cotransfected with 1 mg
supercoiled BAC E11-IGR-b-catenin-ERa and 0.1 mg of renilla luciferase-
encoding pRLSV40 DNA by lipofectamine reagent. Cells were left
untreated or exposed to indicated concentrations of Tet or Dox 24 hours
after transfection and luciferase activity was measured in cell extracts
24 hours later. Data from 3 independent experiments are represented as
means plus standard deviation (SD). The SD values are too small to be
visible in the first five bars. The relative luciferase activity of Tet and Dox
untreated cells were set as 1 arbitrarily (* P,0.05, ** P,0.001 versus cells
unexposed to Tet and Dox). (B) The expression of b-catenin-ERa fusion
protein induced by Tet or Dox was verified by western blotting with the
bands of endogenous b-catenin as loading controls.
doi:10.1371/journal.pone.0006445.g002
Figure 3. The EGFP is an effective selection marker for FACS. (A)
32D cells were mock transfected or transfected with I-SceI-linearized
BAC E11-IGR-b-catenin-ERa DNA by electroporation. The BAC-transfect-
ed cells were sorted by FACS 24 hours after transfection and the sorted
cells were incubated at 37uCi n5 %C O 2 for another 24 hours. The EGFP
fluorescence was compared by flow cytometry. In the range of the
indicated marker, there are 0.84, 7.97 and 67.76% of EGFP positive cells
in mock, unsorted and sorted cell populations respectively. (B) HTB56
cells were mock transfected or transfected with supercoiled BAC E11-
IGR-b-catenin-ERa DNA by lipofectamine reagent. The BAC-transfected
cells were sorted by FACS 24 hours after transfection and the sorted
cells were incubated at 37uCi n5 %C O 2 for another 24 hours. Compared
by flow cytometry, there are 0.16, 9.80 and 79.05% of EGFP positive cells
in mock, unsorted and sorted cell populations respectively in the range
of the indicated marker.
doi:10.1371/journal.pone.0006445.g003
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Supporting Information S1 It is the full sequence of the shuttle
vector, named pIGR-RFC, in current study.
Found at: doi:10.1371/journal.pone.0006445.s001 (0.04 MB
DOC)
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